| Literature DB >> 35896903 |
Shaimaa Mosallam1, Rofida Albash2, Manar Adel Abdelbari3.
Abstract
Fungal infections are considered one of the most serious conditions as their occurrence has increased lately. Fungi like Candida, Fusarium, and Aspergillus species mostly affect immunocompromised patients as they are considered opportunistic pathogens. These infections can be superficial, cutaneous, subcutaneous, or systemic fungal infections that require specific treatment. There is a wide variety of antifungal drugs that can be used to cure fungal infections; however, most of them have many systemic side effects due to their physicochemical characteristics and high toxicity profile. Hence, the current review focuses on various advanced vesicular carriers with high biocompatibility that can encapsulate the antifungal drugs owing to increase their efficacy and limit the undesirable side effects. These advanced systems can manage stability, solubility, bioavailability, safety, and effectiveness issues present in conventional systems.Entities:
Keywords: Advanced vesicular carriers; Antifungal drugs; Conventional systems; Fungal infections
Mesh:
Substances:
Year: 2022 PMID: 35896903 DOI: 10.1208/s12249-022-02357-y
Source DB: PubMed Journal: AAPS PharmSciTech ISSN: 1530-9932 Impact factor: 4.026